RecruitingNCT05994976
Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers
Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers for Molecular Characterization of Inflammatory Skin Diseases
Sponsor
Innovaderm Research Inc.
Enrollment
500 participants
Start Date
Oct 17, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of the study is to collect different samples for molecular characterization of inflammatory skin diseases.
Eligibility
Min Age: 18 Years
Inclusion Criteria22
- All subjects:
- Subject is willing to participate and is capable of giving informed consent. Note: Consent must be obtained prior to any study-related procedures.
- Subject must be willing to comply with all study procedures and must be available for the duration of the study.
- Healthy volunteers:
- Male or female subject aged 18 years or older, at the time of consent.
- Subject is in good general health, according to the investigator's judgment.
- Subjects with Acne:
- Male or female subject aged 18 to 45 years old, inclusive, at the time of consent.
- Subjects with AD:
- Male or female subject aged 18 years or older, at the time of consent.
- Subject has clinically confirmed diagnosis of active AD, according to Hanifin and Rajka criteria.
- Subjects with CHE:
- Male or female subject aged 18 years or older, at the time of consent.
- Subject has at least a 6-month history of CHE before Screening (information obtained from medical chart or subject's physician, or directly from the subject).
- Subjects with HS:
- Male or female subject aged 18 years or older, at the time of consent.
- Subject has a clinically confirmed diagnosis of active HS with a disease duration of ≥ 6 months before screening as determined by the investigator through subject interview and/or review of the medical history.
- Subjects with PPP:
- Male or female subject aged 18 years or older at the time of consent.
- Subject has at least a 6-month history of PPP as defined by the presence of pustules on palms and/or soles, but without evidence of infection on palms and soles (information obtained from medical chart or subject's physician, or directly from the subject).
- Subjects with psoriasis:
- Male or female subject aged 18 years or older, at the time of consent.
Exclusion Criteria3
- All subjects:
- Subject is a female who is pregnant or who is planning to become pregnant during the study.
- Subject has a history of skin disease or presence of skin condition that, in the opinion of the investigator, would interfere with the study assessments.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREBlood samples collection
biomarkers and optional genetic analysis
PROCEDUREOral samples collection
biomarkers analysis
PROCEDUREHair samples collection
biomarkers analysis
PROCEDURESkin samples collection (skin tape strip and/or skin biopsy, and/or skin scraping)
biomarkers analysis
PROCEDURESkin surface material samples
biomarkers analysis
PROCEDUREDrainage fluid samples collection
biomarkers analysis
PROCEDUREStool samples collection
biomarkers analysis
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05994976
Related Trials
Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
NCT072629831 location
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
NCT0688819311 locations
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis
NCT0726547948 locations
A Study Evaluating TRIV-509 in Atopic Dermatitis
NCT0716775844 locations
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
NCT07116967350 locations